JP2014508298A5 - - Google Patents

Download PDF

Info

Publication number
JP2014508298A5
JP2014508298A5 JP2013555939A JP2013555939A JP2014508298A5 JP 2014508298 A5 JP2014508298 A5 JP 2014508298A5 JP 2013555939 A JP2013555939 A JP 2013555939A JP 2013555939 A JP2013555939 A JP 2013555939A JP 2014508298 A5 JP2014508298 A5 JP 2014508298A5
Authority
JP
Japan
Prior art keywords
biomarkers
expression
pancreatic cancer
measuring
biomarkers listed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013555939A
Other languages
English (en)
Japanese (ja)
Other versions
JP6161542B2 (ja
JP2014508298A (ja
Filing date
Publication date
Priority claimed from GBGB1103726.4A external-priority patent/GB201103726D0/en
Application filed filed Critical
Publication of JP2014508298A publication Critical patent/JP2014508298A/ja
Publication of JP2014508298A5 publication Critical patent/JP2014508298A5/ja
Application granted granted Critical
Publication of JP6161542B2 publication Critical patent/JP6161542B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013555939A 2011-03-04 2012-03-05 方法、アレイ及びその使用 Expired - Fee Related JP6161542B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1103726.4A GB201103726D0 (en) 2011-03-04 2011-03-04 Method, array and use thereof
GB1103726.4 2011-03-04
PCT/GB2012/050483 WO2012120288A2 (en) 2011-03-04 2012-03-05 Method, array and use thereof

Publications (3)

Publication Number Publication Date
JP2014508298A JP2014508298A (ja) 2014-04-03
JP2014508298A5 true JP2014508298A5 (enExample) 2015-04-16
JP6161542B2 JP6161542B2 (ja) 2017-07-12

Family

ID=43923218

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013555939A Expired - Fee Related JP6161542B2 (ja) 2011-03-04 2012-03-05 方法、アレイ及びその使用

Country Status (9)

Country Link
US (4) US9863960B2 (enExample)
EP (1) EP2681563A2 (enExample)
JP (1) JP6161542B2 (enExample)
KR (2) KR102014890B1 (enExample)
CN (2) CN103534594A (enExample)
CA (1) CA2828338A1 (enExample)
GB (1) GB201103726D0 (enExample)
MX (1) MX363201B (enExample)
WO (1) WO2012120288A2 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2490025A3 (en) 2007-03-27 2012-11-28 Immunovia AB Method, array and use thereof
GB201103726D0 (en) 2011-03-04 2011-04-20 Immunovia Ab Method, array and use thereof
GB201319878D0 (en) * 2013-11-11 2013-12-25 Immunovia Ab Method, Array and use thereof
KR101658164B1 (ko) * 2014-04-28 2016-09-21 서강대학교산학협력단 브롬 동위원소 신호를 이용한 자유 라디칼-개시 펩타이드 시퀀싱 질량분석
KR20150129932A (ko) * 2014-05-12 2015-11-23 연세대학교 산학협력단 보체인자 b 단백질에 특이적으로 결합하는 항체를 포함하는 췌장암 진단용 키트
CN105572276B (zh) * 2014-11-07 2018-12-18 上海市第六人民医院 胰腺癌诊断标记物组合、应用及其测定方法
CN104698170A (zh) * 2015-03-17 2015-06-10 任传利 Il-11作为生物标记物在胰腺癌诊断和预后评价的方法
EP3073268A1 (en) * 2015-03-27 2016-09-28 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts Biomarker panel for diagnosing cancer
JP5852759B1 (ja) * 2015-04-01 2016-02-03 株式会社キュービクス 遺伝子発現解析による膵臓癌の検出
GB201516801D0 (en) 2015-09-22 2015-11-04 Immunovia Ab Method, array and use thereof
JP5970123B1 (ja) * 2015-12-04 2016-08-17 株式会社キュービクス 遺伝子発現解析による膵臓癌の検出
JP6392201B2 (ja) * 2015-12-04 2018-09-19 株式会社キュービクス 遺伝子発現解析による膵臓癌の検出
CN109642905B (zh) * 2016-02-05 2020-02-07 丹纳基因有限公司 采用与c1灭活因子结合的抗体、与c反应蛋白结合的抗体和/或与补体成分c4结合的抗体诊断和治疗癌症的方法
GB201608192D0 (en) * 2016-05-10 2016-06-22 Immunovia Ab Method, array and use thereof
WO2018112460A1 (en) 2016-12-16 2018-06-21 The Brigham And Women's Hospital, Inc. System and method for protein corona sensor array for early detection of diseases
US20210072255A1 (en) 2016-12-16 2021-03-11 The Brigham And Women's Hospital, Inc. System and method for protein corona sensor array for early detection of diseases
GB201701572D0 (en) 2017-01-31 2017-03-15 Immunovia Ab Methods, arrays and uses thereof
KR102536314B1 (ko) * 2018-05-23 2023-05-25 주식회사 휴벳바이오 질환의 진단용 조성물
SG11202104619WA (en) 2018-11-07 2021-06-29 Seer Inc Compositions, methods and systems for protein corona analysis and uses thereof
CN113454459A (zh) * 2019-02-18 2021-09-28 利物浦大学 诊断方法
KR102829707B1 (ko) 2019-03-26 2025-07-04 시어 인코퍼레이티드 생체 유체로부터의 단백질 코로나 분석을 위한 조성물, 방법 및 시스템 및 그것들의 용도
CN117233413A (zh) 2019-08-05 2023-12-15 禧尔公司 用于样品制备、数据生成和蛋白质冠分析的系统和方法
GB202010970D0 (en) * 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof
EP4204580A4 (en) 2020-08-25 2025-03-19 Seer, Inc. Compositions and methods for assaying proteins and nucleic acids
CN113655144A (zh) * 2021-08-09 2021-11-16 大连医科大学附属第一医院 一种基于丙酮酸激酶和α-2-HS-糖蛋白的早期预警重症急性胰腺炎的预测模型

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0039578B1 (en) 1980-05-02 1985-04-10 Edward P. Davis Leg aid device
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US5856090A (en) 1994-09-09 1999-01-05 The Scripps Research Institute DNA-methylase linking reaction
GB9703369D0 (en) 1997-02-18 1997-04-09 Lindqvist Bjorn H Process
JP4194080B2 (ja) 2003-02-19 2008-12-10 茂 森村 膵癌検出用マーカー
US20050277137A1 (en) * 2003-08-15 2005-12-15 University Of Pittsburgh Diagnostic multimarker serological profiling
US20060106119A1 (en) 2004-01-12 2006-05-18 Chang-Jie Guo Novel integration for CO and H2 recovery in gas to liquid processes
WO2006039671A2 (en) * 2004-09-29 2006-04-13 Central Institute For Experimental Animals Gene markers of tumor metastasis
US8383357B2 (en) 2005-03-16 2013-02-26 OSI Pharmaceuticals, LLC Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
EP2083088A3 (en) 2005-04-07 2009-10-14 Novartis Vaccines and Diagnostics, Inc. Cancer-related genes
CA2604885A1 (en) 2005-04-07 2006-10-19 Guoying Yu Cacna1e in cancer diagnosis, detection and treatment
JP2007051880A (ja) 2005-08-15 2007-03-01 Tokyo Univ Of Science 膵臓癌の検出方法、膵臓癌の診断キット
WO2007107774A2 (en) * 2006-03-22 2007-09-27 Cartela R & D Ab Integrin alpha-10 subunit as therapeutic target and diagnostic/prognostic marker for cancer
KR100819122B1 (ko) * 2006-09-30 2008-04-04 남명진 췌장암 진단용 키트
RU2473555C2 (ru) 2006-12-19 2013-01-27 ДжинГоу, Инк. Новые способы функционального анализа большого количества экспериментальных данных и групп генов, идентифицированных из указанных данных
EP2490025A3 (en) * 2007-03-27 2012-11-28 Immunovia AB Method, array and use thereof
GB0723179D0 (en) * 2007-11-27 2008-01-02 Immunovia Ab Diagnostic methods and arrays for use in the same
EP2326734B1 (en) * 2008-09-03 2016-11-09 The Johns Hopkins University Pathways underlying pancreatic tumorigenesis and an hereditary pancreatic cancer gene
WO2010102195A2 (en) * 2009-03-06 2010-09-10 The Johns Hopkins University Annexin a11 and associated genes as biomarkers for cancer
CN101880707A (zh) * 2009-05-05 2010-11-10 中国人民解放军第二军医大学 microRNA-21在鉴别胰腺癌中的应用
CN101613748A (zh) * 2009-06-09 2009-12-30 中国人民解放军第二军医大学 一种检测胰腺癌血清标志物的方法
SG168431A1 (en) * 2009-07-23 2011-02-28 Univ Singapore Cancer biomarker and the use thereof
GB201103726D0 (en) 2011-03-04 2011-04-20 Immunovia Ab Method, array and use thereof
GB201319878D0 (en) 2013-11-11 2013-12-25 Immunovia Ab Method, Array and use thereof

Similar Documents

Publication Publication Date Title
JP2014508298A5 (enExample)
BR112012019542A2 (pt) "método para avaliar o estado renal em um indivíduo, medição de um ou mais biomarcadores, e, kit"
JP2013521763A5 (enExample)
JP2011524537A5 (enExample)
JP2015505370A5 (enExample)
JO3812B1 (ar) أجسام مضادة ترتبط بالمركب الترابطي البشري للموت المبرمج 1 (pd-l1)
JP2012509477A5 (enExample)
JP2006225396A5 (enExample)
WO2011109372A8 (en) Ultra-sensitive detection of molecules using dual detection methods
JP2013533469A5 (enExample)
WO2012006632A3 (en) Lung cancer biomarkers and uses thereof
ATE538386T1 (de) Nachweis von krebs anhand von erhöhten bcl-2- konzentrationen
JP2010538282A5 (enExample)
JP2016503301A5 (enExample)
WO2008134526A3 (en) Glycoprotein profiling of bladder cancer
JP2013539867A5 (enExample)
WO2012120288A3 (en) Method, array and use for determining the presence of pancreatic cancer.
WO2012075506A3 (en) Methods for predicting and treating infection-induced illnesses and predicting the severity of infection-induced illnesses
WO2013062515A3 (en) Lung cancer biomarkers and uses thereof
Prassas et al. Translational researchers beware! Unreliable commercial immunoassays (ELISAs) can jeopardize your research
JP2012501318A5 (enExample)
JP2018528441A5 (enExample)
Dunphy et al. Clinical proteomics of biofluids in haematological malignancies
WO2009121024A3 (en) Methods for detecting antibodies
Jalali et al. Aptamer based diagnosis of crimean-congo hemorrhagic fever from clinical specimens